SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
Article in CNS Drugs (February 2024)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Article in CNS Drugs (February 2024)
Article in Frontiers in Aging Neuroscience (February 2024)
Article in Cell Reports Medicine (February 2024)